BioNxt Solutions Inc.

C$0.26As of Sun 8 Nov 2026, 12:00 UTC
CSE:BNXTHealthcare
Country Canada
PE (Fwd) •••
TSR 7Y CAGR (20.06%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.58
PE TTM —
TSR TTM (67.90%)
Mkt cap C$35.38M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.266
2.13%
(30.78%)
Hold 3|12|10|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
28.30%
18.86%
5.93%
11.00%
Revenue$M
4.163
4.178
4.356
4.273
1.34%
2.36%
4.30%
2.94%
Peers (US$25.05M)
Cap (US$)
PE
24.68M
—
Capital
TTM
5Y
10Y
Leveragex
1.039
0.187
0.139
EBIT/Intx
0.065
0.232
0.218
Own earn%
(5.62)
85.82
152.21
Sh yield%
15.78
29.42
32.93
Owners
Insiders/Inst%
3.08
31.55
Short interest%
0.97
SBC / revenue%
3.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
20–25
$1 testx
−6.1
Incr. ROIC%
4